Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Strahlenther Onkol ; 199(11): 973-981, 2023 11.
Artigo em Inglês | MEDLINE | ID: mdl-37268767

RESUMO

PURPOSE: The aim of this study was to evaluate interobserver agreement (IOA) on target volume definition for pancreatic cancer (PACA) within the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Society of Radiation Oncology (DEGRO) and to identify the influence of imaging modalities on the definition of the target volumes. METHODS: Two cases of locally advanced PACA and one local recurrence were selected from a large SBRT database. Delineation was based on either a planning 4D CT with or without (w/wo) IV contrast, w/wo PET/CT, and w/wo diagnostic MRI. Novel compared to other studies, a combination of four metrics was used to integrate several aspects of target volume segmentation: the Dice coefficient (DSC), the Hausdorff distance (HD), the probabilistic distance (PBD), and the volumetric similarity (VS). RESULTS: For all three GTVs, the median DSC was 0.75 (range 0.17-0.95), the median HD 15 (range 3.22-67.11) mm, the median PBD 0.33 (range 0.06-4.86), and the median VS was 0.88 (range 0.31-1). For ITVs and PTVs the results were similar. When comparing the imaging modalities for delineation, the best agreement for the GTV was achieved using PET/CT, and for the ITV and PTV using 4D PET/CT, in treatment position with abdominal compression. CONCLUSION: Overall, there was good GTV agreement (DSC). Combined metrics appeared to allow a more valid detection of interobserver variation. For SBRT, either 4D PET/CT or 3D PET/CT in treatment position with abdominal compression leads to better agreement and should be considered as a very useful imaging modality for the definition of treatment volumes in pancreatic SBRT. Contouring does not appear to be the weakest link in the treatment planning chain of SBRT for PACA.


Assuntos
Adenocarcinoma , Neoplasias Pulmonares , Neoplasias Pancreáticas , Radiocirurgia , Humanos , Radiocirurgia/métodos , Adenocarcinoma/diagnóstico por imagem , Adenocarcinoma/radioterapia , Adenocarcinoma/cirurgia , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Variações Dependentes do Observador , Neoplasias Pancreáticas/diagnóstico por imagem , Neoplasias Pancreáticas/radioterapia , Neoplasias Pancreáticas/cirurgia , Planejamento da Radioterapia Assistida por Computador/métodos , Neoplasias Pulmonares/radioterapia , Neoplasias Pancreáticas
2.
Brain Res ; 903(1-2): 62-5, 2001 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-11382388

RESUMO

Nicotine-induced catecholamine (CA) secretion and inward ionic currents were inhibited by the opioid antagonist naloxone in cultured bovine chromaffin cells. Naloxone inhibited nicotine-induced CA secretion, as detected by an on-line real-time electrochemical technique, in a dose-dependent manner (IC(50)=29 microM). In voltage-clamped chromaffin cells, nicotine (10 microM) evoked an average peak inward current of -146 pA that was inhibited by low concentrations of naloxone (42% at 0.1 microM). The antagonist also inhibited total charge influx associated with nicotinic receptor activation (53% at 0.1 microM). This provides strong evidence that naloxone modulation of nicotine-induced CA secretion does not involve opioid receptors but results from the direct interaction with the nicotinic receptor itself, which might also be the case for other related opioid compounds.


Assuntos
Catecolaminas/metabolismo , Células Cromafins/fisiologia , Naloxona/farmacologia , Antagonistas de Entorpecentes/farmacologia , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Animais , Bovinos , Células Cromafins/citologia , Células Cromafins/metabolismo , Relação Dose-Resposta a Droga , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Peptídeos Opioides/antagonistas & inibidores , Técnicas de Patch-Clamp , Receptores Nicotínicos/fisiologia
3.
FEBS Lett ; 418(1-2): 39-42, 1997 Nov 24.
Artigo em Inglês | MEDLINE | ID: mdl-9414091

RESUMO

Nicotine-induced ATP secretion from chromaffin cells was blocked by imipramine and desipramine. This blocking action took place on both, fast and slow, components of ATP secretion. Exposure of chromaffin cells to nicotine (10 microM) for 4 s induced an inward current of about -155 pA. Imipramine and desipramine blocked, in a concentration-dependent manner, both peak inward current and total charge influx in response to nicotine. In addition, imipramine and desipramine partially (40%) blocked depolarization-induced ATP secretion and Ca2+ currents evoked by high K+. This suggests that tricyclic antidepressants block nicotine-induced ATP secretion by acting on two targets: one is the nicotinic receptor itself and the second one are voltage-dependent Ca2+ channels.


Assuntos
Trifosfato de Adenosina/metabolismo , Antidepressivos Tricíclicos/farmacologia , Células Cromafins/fisiologia , Desipramina/farmacologia , Imipramina/farmacologia , Nicotina/farmacologia , Antagonistas Nicotínicos , Receptores Nicotínicos/fisiologia , Animais , Bovinos , Células Cultivadas , Células Cromafins/citologia , Células Cromafins/efeitos dos fármacos , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Potássio/farmacologia , Receptores Nicotínicos/efeitos dos fármacos
4.
J Neurochem ; 67(3): 1056-62, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8752112

RESUMO

An increase in extracellular Ca2+ concentration from 0.25 to 10 mM enhanced secretion of norepinephrine and epinephrine induced by a high extracellular K+ concentration (75 mM). The increment in extracellular Ca2+ concentration also increased the observed peak inward Ca2+ current in response to long (10-s) depolarizing pulses from a holding potential of -55 mV to +5 mV, from about -26 to -400 pA. However, the total amount of Ca2+ influx into the cell only increased when the extracellular Ca2+ concentration was raised from 0.25 to 1 mM and then remained constant up to 10 mM extracellular Ca2+. ATP is cosecreted with catecholamines following a depolarizing stimulus. Kinetic studies indicated that ATP secretion had two components with time constants, in the presence of 2.5 mM extracellular Ca2+, of approximately 4 and 41 s, being the fast component of secretion produced by the exocytosis of approximately 220 chromaffin granules. The results suggest that, for a given depolarizing stimulus, the size and rate of release for the fast and slow components of secretion are dependent on extracellular Ca2+ concentration.


Assuntos
Cálcio/farmacologia , Sistema Cromafim/citologia , Sistema Cromafim/fisiologia , Trifosfato de Adenosina/metabolismo , Animais , Cálcio/metabolismo , Canais de Cálcio/fisiologia , Bovinos , Células Cultivadas/metabolismo , Células Cultivadas/fisiologia , Condutividade Elétrica , Eletrofisiologia , Cinética , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia
5.
Neurosci Lett ; 191(1-2): 59-62, 1995 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-7659292

RESUMO

We have studied the contribution of N-type voltage-dependent Ca2+ channels to both norepinephrine and epinephrine secretion from bovine chromaffin cells induced by high K+ or nicotine using omega-conotoxin GVIA, a selective blocker of N-type voltage-dependent Ca2+ channels. We found that high K+ (75 mM) induced catecholamine secretion was not affected by exposure of bovine chromaffin cells to omega-conotoxin GVIA (1 microM). However, nicotine-induced both norepinephrine and epinephrine secretion were similarly blocked (about 25%) by omega-conotoxin GVIA (1 microM). This effect could be explained by a potent (about 80%) and reversible blockade of the inward current induced by nicotine receptor activation in bovine chromaffin cells. The results indicate that besides the blockade of N-type voltage-dependent channels, omega-conotoxin GVIA is a potent and reversible blocker of the nicotinic receptor-induced currents in chromaffin cells.


Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/metabolismo , Catecolaminas/metabolismo , Sistema Cromafim/metabolismo , Nicotina/antagonistas & inibidores , Peptídeos/farmacologia , Receptores Nicotínicos/metabolismo , Acetilcolina/metabolismo , Animais , Canais de Cálcio/efeitos dos fármacos , Bovinos , Sistema Cromafim/citologia , Sistema Cromafim/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Eletroquímica , Epinefrina/metabolismo , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Norepinefrina/metabolismo , Técnicas de Patch-Clamp , Potássio/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , ômega-Conotoxina GVIA
6.
FEBS Lett ; 362(1): 15-8, 1995 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-7698345

RESUMO

We have studied the contribution of P-type voltage-dependent Ca2+ channels to both catacholamine (CA) and ATP secretion from bovine chromaffin cells induced by high K+ or nicotine using omega-agatoxin IVA, a selective blocker of P-type voltage-dependent Ca2+ channels. We found that high K+ (75 mM) induced the release of about 13% of norepinephrine, 5% epinephrine and 11% ATP, and that omega-agatoxin (100 nM) did not affect this secretion. However, both nicotine-induced CA and ATP secretion were significantly blocked (about 50%) by omega-agatoxin IVA (100 nM). In addition, this toxin also reversibly blocked (about 70%) the inward current induced by nicotine in bovine chromaffin cells. The results suggest that, besides its known action of blocking P-type voltage-dependent channels, omega-agatoxin is a potent and reversible blocker of the nicotinic receptor channel in chromaffin cells, and that this action would explain the blockade of nicotine-induced secretion.


Assuntos
Medula Suprarrenal/efeitos dos fármacos , Canais de Cálcio/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacos , Venenos de Aranha/farmacologia , Trifosfato de Adenosina/metabolismo , Medula Suprarrenal/metabolismo , Animais , Canais de Cálcio/metabolismo , Bovinos , Células Cultivadas , Epinefrina/metabolismo , Nicotina/farmacologia , Norepinefrina/metabolismo , Técnicas de Patch-Clamp , Potássio/farmacologia , Receptores Nicotínicos/metabolismo , ômega-Agatoxina IVA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA